BIS-RNAI
DEAD

Serial Number

86778596

Owner

Alnylam Pharmaceuticals, Inc.

Attorney

Ann Lamport Hammitte

Filing Date

Oct 5, 2015

Add to watchlist:

No watchlists yet
View on USPTO

BIS-RNAI Trademark

Serial Number: 86778596

BIS-RNAI is a trademark filed by Alnylam Pharmaceuticals, Inc. on October 5, 2015. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Alnylam Pharmaceuticals, Inc. (91 trademarks)

300 Third Street, 3rd Floor
Cambridge, MA 02142

Entity Type: 03

Trademark Details

Filing Date

October 5, 2015

Registration Date

Not Registered

Published for Opposition

September 27, 2016

Goods & Services

pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection; pharmaceuticals, biosimilars and biological preparations for medical and therapeutic purposes for use in the treatment of cancer, HIV, hepatitis A, hepatitis B, influenza, measles, neurodegenerative diseases, transthyretin (TTR)-mediated amyloidosis (ATTR), hemophilia, porphyria, complement-mediated disease, hypercholesterolemia, rare genetic diseases, cardio-metabolic diseases, hepatic infectious diseases, hereditary ATTR amyloidosis, rare bleeding disorders, hepatic porphyrias, alpha-1 antitrypsin deficiency, primary hyperoxaluria type 1, beta-thalassemia, iron overload disorders, hereditary angiodema, hypertriglyceridemia, mixed hyperlipidemia, hypertriglyceridemia, hypertension, preeclampsia, thromboprophylaxis, hepatitis B virus infection, hepatitis D virus infection, chronic liver infection

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Dec 23, 2019 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 23, 2019 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
May 29, 2019 EXRA
SOU EXTENSION 5 GRANTED
May 28, 2019 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 28, 2019 AITU
SOU EXTENSION 5 FILED
May 22, 2019 EXT5
SOU TEAS EXTENSION RECEIVED
May 22, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Nov 23, 2018 EXRA
SOU EXTENSION 4 GRANTED
Nov 21, 2018 EX4G
SOU EXTENSION 4 FILED
Nov 21, 2018 EXT4
SOU TEAS EXTENSION RECEIVED
Nov 21, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Apr 3, 2018 EXRA
SOU EXTENSION 3 GRANTED
Mar 30, 2018 EX3G
SOU EXTENSION 3 FILED
Mar 30, 2018 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 30, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Nov 21, 2017 EXRA
SOU EXTENSION 2 GRANTED
Nov 17, 2017 EX2G
SOU EXTENSION 2 FILED
Nov 17, 2017 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 17, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
May 23, 2017 EXRA
SOU EXTENSION 1 GRANTED
May 19, 2017 EX1G
SOU EXTENSION 1 FILED
May 19, 2017 EXT1
SOU TEAS EXTENSION RECEIVED
May 19, 2017 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Nov 22, 2016 NOAM
PUBLISHED FOR OPPOSITION
Sep 27, 2016 PUBO
NOTICE OF PUBLICATION
Sep 7, 2016 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 19, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 6, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 5, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 5, 2016 CRFA
ASSIGNED TO LIE
Aug 1, 2016 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 26, 2016 TROA
NON-FINAL ACTION MAILED
Jan 27, 2016 CNRT
NON-FINAL ACTION WRITTEN
Jan 23, 2016 CNRT
ASSIGNED TO EXAMINER
Jan 22, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 8, 2015 NWOS
NEW APPLICATION ENTERED
Oct 8, 2015 NWAP